Efficacy and safety of bismuth-based quadruple therapy for Helicobacter pylori eradication in children.

Kallirroi KotileaSamy CadranelAssaad SalameJulie NguyenTania MahlerVéronique Yvette Miendje DeyiLaurine VersetPatrick Bontems

Published in: Helicobacter (2021)

10-day quadruple therapy containing CBS, ESO, AMO, and MET for H. pylori eradication in children is a safe and very effective solution, especially for previously treated patients and those infected with double resistant strains.

Keyphrases

helicobacter pylori
helicobacter pylori infection
end stage renal disease
young adults
newly diagnosed
chronic kidney disease
escherichia coli
peritoneal dialysis
prognostic factors
patient reported outcomes
patient reported
solid state